For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Freenome Holdings, Inc.

Calculating rank

USPTO Granted Patents = 14

EPO Patents = 1

Trademarks = 3

Forward Citations = 48

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Adam Drake (6 out of 6 patents)

Eric Ariazi (4 out of 4 patents)

Daniel Delubac (4 out of 4 patents)

4. John St John (3 out of 3 patents)

5. Greg Hogan (2 out of 4 patents)

6. Gabriel Otte (2 out of 2 patents)

7. Charles Roberts (2 out of 2 patents)

8. Riley Charles Ennis (2 out of 2 patents)

9. Nathan Wan (2 out of 2 patents)

10. Tzu-Yu Liu (2 out of 2 patents)

11. Imran Haque (2 out of 2 patents)

12. Katherine Niehaus (2 out of 2 patents)

13. Ajay Kannan (2 out of 2 patents)

14. Brandon White (2 out of 2 patents)

15. Brian D O'donovan (2 out of 2 patents)

14 patents: Sort by Forward Citations

1. 12763168 - Methods and systems for detecting cancer via nucleic acid methylation analysis (2026-10-13),

2. 12716896 - Antibody assay for the detection and treatment of liver cancer (2026-08-25),

3. 12682984 - Transcription factor profiling (2026-07-14),

4. 12503728 - METHODS AND SYSTEMS FOR HIGH-DEPTH SEQUENCING OF METHYLATED NUCLEIC ACID (2025-12-23),

5. 12454724 - Methods and systems for high-depth sequencing of methylated nucleic acid (2025-10-28),

6. 12410480 - Methods and systems for detecting colorectal cancer via nucleic acid methylation analysis (2025-09-09),

7. 12372528 - Markers for the early detection of colon cell proliferative disorders (2025-07-29),

8. 12247905 - Methods and systems for sample extraction (2025-03-11),

9. 12242943 - Generating machine learning models using genetic data (2025-03-04),

10. 12228574 - Markers for the early detection of colon cell proliferative disorders (2025-02-18),

11. 11847532 - Machine learning implementation for multi-analyte assay development and testing (2023-12-19),

12. 11781959 - Methods and systems for sample extraction (2023-10-10),

13. 11681953 - Machine learning implementation for multi-analyte assay development and testing (2023-06-20),

14. 11514289 - Generating machine learning models using genetic data (2022-11-29),

Company Overview

Freenome Holdings, Inc. is a biotechnology company based in South San Francisco, California, specializing in early cancer detection through advanced blood testing technologies. The organization leverages artificial intelligence and machine learning to analyze genomic and proteomic data, aiming to identify cancer at its earliest stages. Freenome's innovative approach focuses on non-invasive methods to improve patient outcomes and enhance the accuracy of cancer diagnostics, contributing to the evolving landscape of personalized medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

14 Patents

#82 in South San Francisco, CA

#5,325 in California

#22,344 in US

#42,312 in the World

South San Francisco, CA, United States of America

Freenome Holdings, Inc.

Forward Citations = 48

31 inventors:

Adam Drake (6 out of 6 patents)

Eric Ariazi (4 out of 4 patents)

Daniel Delubac (4 out of 4 patents)

4. John St John (3 out of 3 patents)

5. Greg Hogan (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Freenome Holdings, Inc.. Retrieved from https://idiyas.com/company/freenome-holdings

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…